4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
COSCIENS Biopharma Inc. (CSCI) operates in the Biotechnology industry and is headquartered in Toronto, Canada with about 28 employees. Its market capitalization is roughly C$8 million. In the fiscal year ended 2025-12-31, CSCI reported $8M in revenue and ($10M) in net income.
COSCIENS Biopharma Inc., a life science company, develops and commercializes products for the cosmeceutical, nutraceutical and pharmaceutical markets in the United States, Germany, the United Kingdom, and internationally. It operates through Active Ingredient and Pharmaceutical segments.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $8M | $10M | $7M | $15M | — |
| Gross Profit | $3M | $5M | $3M | $9M | — |
| Operating Income (EBIT) | ($10M) | ($14M) | ($5M) | $4M | — |
| Net Income | ($10M) | ($15M) | ($4M) | $3M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $2M | $2M | $2M | $3M | $1M | — |
| Gross Profit | $1M | $1M | $1M | $1M | $0M | — |
| Operating Income (EBIT) | ($1M) | ($2M) | ($2M) | ($2M) | ($3M) | — |
| Net Income | $11M | ($2M) | ($2M) | ($3M) | ($4M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $21M | $35M | $24M | $28M | — |
| Total Liabilities | $18M | $22M | $3M | $4M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive CSCI viewer.
About TickerBase · Data methodology & sources · Privacy · Terms